Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (151-160 of 381) with videos related to

Pageof 39
Sort By:
Tumori|May 20, 2022
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysisMatteo Santoni, Francesco Massari, Alessandro Rizzo, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-AnalysisAlessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, et al.
Future Oncology (London, England)|April 5, 2022
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancerAlessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Mendelian Randomization Studies of Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Cancers. A PRISMA Review and Meta-AnalysisElsa Vitale, Lorenza Maistrello, Alessandro Rizzo, et al.
Expert Review of Clinical Pharmacology|April 27, 2026
Predictive and prognostic factors for immunotherapy response in head and neck squamous cell carcinoma: a narrative reviewConcetta Calabrò, Giuseppe De Palma, Tarik Gheit, et al.
Cancers|May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-AnalysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Expert Review of Anticancer Therapy|December 29, 2025
Elacestrant in metastatic breast cancer: current advancements and future perspectivesTaha Koray Sahin, Binura Makasheva, Deniz Can Guven, et al.
Frontiers in Oncology|May 11, 2023
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issueGiovanni Brandi, Chiara Deiana, Linda Galvani, et al.
Advanced Theory and Simulations|May 11, 2022
Predicting the Effects of Waning Vaccine Immunity Against COVID-19 through High-Resolution Agent-Based ModelingAgnieszka Truszkowska, Lorenzo Zino, Sachit Butail, et al.
Advanced Theory and Simulations|January 31, 2023
Exploring a COVID-19 Endemic Scenario: High-Resolution Agent-Based Modeling of Multiple VariantsAgnieszka Truszkowska, Lorenzo Zino, Sachit Butail, et al.
Pageof 39

Showing results (151-160 of 381) with videos related to

Sort By:
Pageof 39
Tumori|May 20, 2022
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysisMatteo Santoni, Francesco Massari, Alessandro Rizzo, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-AnalysisAlessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, et al.
Future Oncology (London, England)|April 5, 2022
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancerAlessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Mendelian Randomization Studies of Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Cancers. A PRISMA Review and Meta-AnalysisElsa Vitale, Lorenza Maistrello, Alessandro Rizzo, et al.
Expert Review of Clinical Pharmacology|April 27, 2026
Predictive and prognostic factors for immunotherapy response in head and neck squamous cell carcinoma: a narrative reviewConcetta Calabrò, Giuseppe De Palma, Tarik Gheit, et al.
Cancers|May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-AnalysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Expert Review of Anticancer Therapy|December 29, 2025
Elacestrant in metastatic breast cancer: current advancements and future perspectivesTaha Koray Sahin, Binura Makasheva, Deniz Can Guven, et al.
Frontiers in Oncology|May 11, 2023
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issueGiovanni Brandi, Chiara Deiana, Linda Galvani, et al.
Advanced Theory and Simulations|May 11, 2022
Predicting the Effects of Waning Vaccine Immunity Against COVID-19 through High-Resolution Agent-Based ModelingAgnieszka Truszkowska, Lorenzo Zino, Sachit Butail, et al.
Advanced Theory and Simulations|January 31, 2023
Exploring a COVID-19 Endemic Scenario: High-Resolution Agent-Based Modeling of Multiple VariantsAgnieszka Truszkowska, Lorenzo Zino, Sachit Butail, et al.
Pageof 39